文献速递胃肠外科急腹症与外科感染围术期管理与 ERAS

食管癌高量外科医生对上消化道急症处理及死亡率的影响:基于人群的队列研究

Effect of Esophageal Cancer Surgeon Volume on Management and Mortality From Emergency Upper Gastrointestinal Conditions: Population-based Cohort Study.
PubMed 文献 · Ann Surg · 2017-01-01

该研究利用英格兰医院统计数据分析1997-2012年因食管穿孔、食管旁疝梗阻或坏疽、穿孔性消化性溃疡住院的患者,探讨食管癌高量外科医生(每年≥5例切除)对30天和90天死亡率的影响。结果显示,由高量外科医生管理独立降低三种急症的30天和90天死亡率,且高量外科医生更常对食管穿孔和食管旁疝行手术治疗,手术与所有三种疾病的死亡率降低独立相关。

要点

  • 高量食管癌外科医生管理独立降低食管穿孔、食管旁疝和穿孔性溃疡的30天和90天死亡率。
  • 高量外科医生更常对食管穿孔和食管旁疝行手术治疗。
  • 手术治疗与三种上消化道急症的死亡率降低独立相关。

核心结论

  • 高量食管癌外科医生的复杂择期工作负荷可能降低对特定上消化道急症(如食管穿孔和食管旁疝)的手术干预阈值,从而降低死亡率。

研究设计与样本

  • 基于英格兰医院统计数据的基于人群的队列研究,纳入1997-2012年因食管穿孔、食管旁疝梗阻或坏疽、穿孔性消化性溃疡住院的患者。
  • 共纳入食管穿孔3707例、食管旁疝12411例、穿孔性消化性溃疡57164例。
  • 高量食管癌外科医生定义为每年≥5例食管切除。

主要发现

  • 食管穿孔、食管旁疝和穿孔性消化性溃疡的观察90天死亡率分别为36.5%、11.5%和29.0%。
  • 高量外科医生管理与食管穿孔30天和90天死亡率降低独立相关(OR 0.51,95%CI 0.40-0.66)。
  • 高量外科医生管理与食管旁疝30天和90天死亡率降低独立相关(OR 0.70,95%CI 0.53-0.91)。
  • 高量外科医生管理与穿孔性消化性溃疡30天和90天死亡率降低独立相关(OR 0.85,95%CI 0.7-0.95)。
  • 高量外科医生更常对食管穿孔(OR 2.38,95%CI 1.87-3.04)和食管旁疝(OR 2.12,95%CI 1.79-2.51)行手术治疗,且手术与所有三种疾病的死亡率降低独立相关。

关键数值与推荐

  • 高量食管癌外科医生定义为每年≥5例食管切除。

临床怎么用

  • 对于食管穿孔、食管旁疝梗阻或坏疽、穿孔性消化性溃疡等上消化道急症,可考虑由高量食管癌外科医生参与管理以降低死亡率。
  • 高量外科医生可能更积极采用手术治疗,从而改善预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the influence of esophageal cancer surgeon volume upon mortality from upper gastrointestinal emergencies. BACKGROUND: Volume-outcome relationships led to the centralization of esophageal cancer surgery. METHODS: Hospital Episode Statistics data were used to identify patients admitted to hospitals within England (1997-2012). The influence of esophageal high-volume (HV) cancer surgeon status (≥5 resections per year) upon 30-day and 90-day mortality from esophageal perforation (EP), paraesophageal hernia causing obstruction or gangrene (PEH) and perforated peptic ulcer (PPU) was analyzed, independent of HV esophageal cancer center status and patient and disease-specific confounding factors. RESULTS: A total of 3707, 12,411, and 57,164 patients with EP, PEH, and PPU, respectively, were included. The observed 90-day mortality was 36.5%, 11.5%, and 29.0% for EP, PEH, and PPU, respectively.Management by HV cancer surgeon was independently associated with significant reductions in 30-day and 90-day mortality from EP (odds ratio, OR 0.51, 95% confidence interval, CI, 0.40-0.66), PEH (OR=0.70, 95% CI 0.53-0.91), and PPU (OR=0.85, 95% CI 0.7-0.95). Subset analysis of those patients receiving primary surgery as treatment showed no change in mortality when performed by HV cancer surgeons.However HV cancer surgeons performed surgery as primary treatment more commonly for EP (OR=2.38, 95% CI 1.87-3.04) and PEH (OR=2.12, 95% CI 1.79-2.51). Furthermore surgery was independently associated with reduced mortality for all 3 conditions. CONCLUSION: The complex elective workload of HV esophageal cancer surgeons appears to lower the threshold for surgical intervention in specific upper gastrointestinal emergencies such as EP and PEH, which in turn reduces mortality.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Markar SR, Mackenzie H, Askari A, et al. Effect of Esophageal Cancer Surgeon Volume on Management and Mortality From Emergency Upper Gastrointestinal Conditions: Population-based Cohort Study. Ann Surg. 2017. PMID: 28704230. doi:10.1097/SLA.0000000000002387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。